ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,436Medicare Part D Prescriptions Filled, Including Refills

Rank: 36 out of 337

$606K Total Retail Price of All Prescriptions

Rank: 45 out of 337

600 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 600 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

6% of this provider’s 600 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 12,289 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
SIMVASTATIN 865 781 1 1
LEVOTHYROXINE SODIUM 675 646 2 5
OMEPRAZOLE 630 577 3 4
AMLODIPINE BESYLATE 475 468 4 3
LISINOPRIL 392 342 5 2
BENAZEPRIL HCL 381 355 6 109
METOPROLOL TARTRATE 378 360 7 6
ATORVASTATIN CALCIUM 338 334 8 7
LISINOPRIL-HYDROCHLOROTHIAZIDE 334 322 9 31
METFORMIN HCL 300 272 10 12
LOVASTATIN 282 281 11 24
FUROSEMIDE 266 255 12 8
ATENOLOL 241 214 13 10
HYDROCHLOROTHIAZIDE 236 221 14 9
HYDROCODONE-ACETAMINOPHEN 209 178 S3 15 13
CITALOPRAM HBR 198 178 16 17
LOSARTAN-HYDROCHLOROTHIAZIDE 192 168 17 60
DIOVAN 178 163 18 26
ZOLPIDEM TARTRATE 173 160 19 23
DIOVAN HCT 166 153 20 88
WARFARIN SODIUM 165 165 21 11
LOSARTAN POTASSIUM 165 150 21 15
SERTRALINE HCL 163 163 23 18
ALPRAZOLAM 163 156 23 78
QUINAPRIL HCL 148 145 25 50
ADVAIR DISKUS 147 135 26 44
JANUVIA 137 125 27 81
SPIRIVA 130 95 28 43
FELODIPINE ER 121 121 29 79
METFORMIN HCL ER 116 98 30 52
CRESTOR 114 93 31 29
FENOFIBRATE 106 94 32 48
TAMSULOSIN HCL 96 96 33 25
TRAZODONE HCL 94 88 34 16
PANTOPRAZOLE SODIUM 92 66 35 36
MELOXICAM 92 68 35 54
PAROXETINE HCL 89 79 37 46
ALENDRONATE SODIUM 89 89 37 19
RANITIDINE HCL 87 86 39 30
BENAZEPRIL-HYDROCHLOROTHIAZIDE 84 84 40 280
LIPITOR 83 80 41 33
BISOPROLOL-HYDROCHLOROTHIAZIDE 83 83 41 95
DIGOXIN 82 82 43 58
ALLOPURINOL 80 80 44 28
METOPROLOL SUCCINATE 79 79 45 21
EXFORGE 79 55 45 226
GLIPIZIDE ER 77 75 47 69
SYNTHROID 74 68 48 41
AMITRIPTYLINE HCL 73 58 R 49 75
GLIPIZIDE 72 62 50 45
VERAPAMIL ER 69 69 51 77
NAMENDA 68 68 52 35
CYMBALTA 68 27 52 59
CLOPIDOGREL 67 66 54 42
KLOR-CON M20 63 61 55 65
DOXAZOSIN MESYLATE 60 60 56 68
DONEPEZIL HCL 58 58 57 22
TRAMADOL HCL 53 37 58 32
PLAVIX 52 52 59 74
LEVOXYL 50 50 60 90
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.